Stocks and Investing
Stocks and Investing
Fri, May 3, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, May 2, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Catherine Schulte Maintained (TECH) at Buy with Increased Target to $81 on, May 2nd, 2024
Catherine Schulte of Baird, Maintained "Bio-Techne Corporation" (TECH) at Buy with Increased Target from $73 to $81 on, May 2nd, 2024.
Catherine has made no other calls on TECH in the last 4 months.
There are 4 other peers that have a rating on TECH. Out of the 4 peers that are also analyzing TECH, 2 agree with Catherine's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Conor McNamara of "RBC Capital" Maintained at Hold with Decreased Target to $75 on, Friday, February 2nd, 2024
- Daniel Arias of "Stifel" Downgraded from Strong Buy to Hold and Held Target at $65 on, Friday, February 2nd, 2024
These are the ratings of the 2 analyists that currently disagree with Catherine
- Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $82 on, Thursday, April 18th, 2024
- Jacob Johnson of "Stephens & Co." Maintained at Buy with Decreased Target to $87 on, Friday, February 2nd, 2024
Contributing Sources